We are live on ! Find out more
Third Rock Ventures

Third Rock Ventures Portfolio holdings

AUM $1.07B Turnover 20%
1-Year Est. Return 170.23%
This Fund
S&P 500
This Quarter Est. Return
+52.99%
1 Year Est. Return
+170.23%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
+$365M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.7 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.7 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SAGE icon
1
DELISTED
Sage Therapeutics
SAGE
$428M 34.97%
11,681,008
– –
2014 Q3
1 quarter
AGIO icon
2
Agios Pharmaceuticals
AGIO
$1.96B
$344M 28.13%
3,070,090
– –
2013 Q4
4 quarters
LRMR icon
3
Larimar Therapeutics
LRMR
$284M
$173M 14.13%
466,837
– –
2014 Q3
1 quarter
BLUE icon
4
DELISTED
bluebird bio
BLUE
$111M 9.11%
93,802
– –
2013 Q4
4 quarters
FMI
5
DELISTED
Foundation Medicine, Inc.
FMI
$109M 8.95%
4,927,234
– –
2013 Q4
4 quarters
CARM icon
6
DELISTED
Carisma Therapeutics
CARM
$57.5M 4.7%
242,080
– –
2014 Q1
3 quarters

Similar funds

Third Rock Ventures's Q4 2014 Portfolio in Review

As of Q4 2014, Third Rock Ventures held 6 positions worth $1.22B, up 43% from $857M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 0%. Third Rock Ventures opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Third Rock Ventures's ten largest holdings make up 100% of its $1.22B portfolio in Q4 2014.
  • Third Rock Ventures opened 0 new positions and closed 0 in Q4 2014.
  • Third Rock Ventures's portfolio value rose 43% quarter-over-quarter to $1.22B.

Based on Third Rock Ventures's 13F filing for Q4 2014, filed 26 Jan 2015.